Data / Form D filings / BICYCLE THERAPEUTICS PLC
BICYCLE THERAPEUTICS PLC: Form D filing
BICYCLE THERAPEUTICS PLC, a pharmaceuticals company in Cambridge, United Kingdom, filed a Form D with the SEC in 2024. The latest, on June 12, 2024, reports $555.5 million sold of a $555.5 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, Cambridge, United Kingdom, CB21
- Phone
- 011441223261503
- Industry
- Pharmaceuticals
- Entity type
- Other (PUBLIC LIMITED COMPANY)
- Incorporated in
- United Kingdom
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1761612
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 12, 2024 | New notice | $555,499,983 | $555,499,983 | 19 | May 28, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| KEVIN LEE | Executive Officer, Director | |
| FELIX J. BAKER | Director | |
| RICHARD N. KENDER | Director | |
| GREGORY N. WINTER | Director | |
| STEPHEN N. SANDS | Director | |
| NIGEL N. CROCKETT | Executive Officer | |
| JOSE-CARLOS J. GUTIERREZ-RAMOS | Director | |
| NICHOLAS N. KEEN | Executive Officer | |
| SANTIAGO N. ARROYO | Executive Officer | |
| PIERRE LEGAULT | Director | |
| MICHAEL N. HANNAY | Executive Officer | |
| MICHAEL N. SKYNNER | Executive Officer | |
| ALISTAIR N. MILNES | Executive Officer | |
| ALETHIA YOUNG | Executive Officer | |
| JANICE J. BOURQUE | Director |
Every Form D from the week of Jun 10, 2024 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what BICYCLE THERAPEUTICS PLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.